Results · Apr-Jun 2026 · filed 7 Aug 2026
Anuh Pharma Q1 FY27 results
Sales grew 4% to ₹194 crore from ₹186 crore in Apr-Jun 2025.
Operating profit grew 58% to ₹16.3 crore, an operating margin of 8.4% (up 2.9 points from a year ago).
Net profit grew 38% to ₹11.4 crore from ₹8.3 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −4%, net profit −2%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 193.8 | 186.5 | +4% |
| Operating profit (EBITDA) | 16.3 | 10.3 | +58% |
| Operating margin | 8.4% | 5.5% | +2.9 pts |
| Net profit | 11.4 | 8.3 | +38% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 12 Aug 2026Shareholder Meeting / Postal Ballot-Outcome of AGM
- 9 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 7 Aug 2026Announcement Under Regulation 30 (LODR) - Adoption Of Revised Policy Of Related Party Transactions,
- 7 Aug 2026Announcement Under Regulation 30 (LODR) - Intimation Regarding The Request Received For Withdrawal Of Application For Reclassification.
- 7 Aug 2026Results - Financial Results For June 30, 2026
- 7 Aug 2026Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/08/2026
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.